Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
28.81
+0.54 (1.91%)
Mar 9, 2026, 3:09 PM EDT - Market open
Assembly Biosciences Market Cap
Assembly Biosciences has a market cap or net worth of $455.69 million as of March 9, 2026. Its market cap has increased by 462.58% in one year.
Market Cap
455.69M
Enterprise Value
232.06M
1-Year Change
462.58%
Ranking
Category
Stock Price
$28.81
Market Cap Chart
Since December 17, 2010, Assembly Biosciences's market cap has increased from $40.20M to $455.69M, an increase of 1,033.56%. That is a compound annual growth rate of 17.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 447.20M | -16.86% |
| Dec 31, 2025 | 537.90M | 436.29% |
| Dec 31, 2024 | 100.30M | 86.09% |
| Dec 29, 2023 | 53.90M | -14.98% |
| Dec 30, 2022 | 63.40M | -43.14% |
| Dec 31, 2021 | 111.50M | -44.19% |
| Dec 31, 2020 | 199.80M | -62.51% |
| Dec 31, 2019 | 532.90M | -7.48% |
| Dec 31, 2018 | 576.00M | -26.83% |
| Dec 29, 2017 | 787.20M | 276.11% |
| Dec 30, 2016 | 209.30M | 61.75% |
| Dec 31, 2015 | 129.40M | 54.60% |
| Dec 31, 2014 | 83.70M | 5.02% |
| Dec 31, 2013 | 79.70M | 185.66% |
| Dec 31, 2012 | 27.90M | -71.93% |
| Dec 30, 2011 | 99.40M | 135.55% |
| Dec 31, 2010 | 42.20M | 4.98% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vanda Pharmaceuticals | 466.36M |
| Kyverna Therapeutics | 462.75M |
| Altimmune | 460.45M |
| Century Therapeutics | 459.90M |
| Entrada Therapeutics | 452.88M |
| Lineage Cell Therapeutics | 448.31M |
| REGENXBIO | 446.45M |
| vTv Therapeutics | 439.40M |